Menu

Higher Blood Pressure Has Links to Brain Lesions in Older Adults

In a longitudinal study, researchers find that elderly people with higher pressure were more likely to show signs of Alzheimer’s disease in brain tissue.

Jul 13, 2018
Sukanya Charuchandra

Older individuals with high blood pressure are more likely to have brain lesions than those without high blood pressure and may also have protein tangles, a sign of Alzheimer’s disease, according to a study published in Neurology on July 11.

Coauthor Zoe Arvanitakis, a neurologist at Rush University Medical Center, says these “preliminary data” need further exploration, according to the Associated Press. “We can’t be alarmist,” she says.

According to a statement, the researchers were keen to learn if blood pressure had links to signs of brain aging. They tracked 1,288 people who were over the age of 65 until their deaths, an average of eight years. The scientists measured the blood pressure of the subjects once every year and examined their brains postmortem. 

Of the total number of subjects, two-thirds of the subjects had high blood pressure, while about half had one or more brain infarcts, necrotic regions caused by a loss of blood flow. With higher blood pressure, the risk of brain lesions went up: people with an upper blood pressure of 147 (normal being 120) had a 46 percent higher chance of having one or more lesions. Additionally, those with high pressure were more likely to have protein tangles in their brains. 

While the paper has “good information,” it also raises many questions, Ajay Misra, a neurologist at New York University Winthrop Hospital who was not involved in this research, tells Health Day. For instance, is higher blood pressure better in some situations? The researchers found that elderly subjects with lower blood pressure had a greater risk of stroke. Misra suggests the higher pressure may be required to keep blood vessels of older adults clear. He adds that a one-size-fits-all blood-pressure guideline may not be appropriate.

“The study further supports treatment of blood pressure in late life to prevent cerebrovascular disease,” Joe Verghese, a professor of neurology and medicine at the Albert Einstein College of Medicine who was not involved in his study, tells CNN. “The story regarding Alzheimer risk is less clear,” he adds. However, previous research has shown similar links between blood pressure and dementia, according to CNN. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.